×

Biogen shows its hand

5:15 PM ET Tue, 2 Dec 2014

CNBC's Meg Tirrell provides insight to Biogen Idec's promising early study on its experimental medicine for Alzheimer's disease. Michael Yee, RBC Capital Markets, explains why the stock is headed higher from here.